Background: High-resolution contrast-enhanced magnetic resonance imaging (CEMRI) has been proven to be an effective tool for the identification of carotid atherosclerotic vulnerable plaque, such as a large lipid core and thin fibrous cap. The aim of this study was to evaluate the relationship between carotid plaque characteristics and the types of stroke in patients who had carotid artery (CA) stenosis ≥50%. Methods: 102 consecutive subjects (mean age 67.2 ± 10.2 years; 73 males) who initially had ischemic stroke or asymptomatic CA stenosis from 50 to 100% diagnosed by ultrasound were included in this study. Carotid CEMRI, brain MRI and magnetic resonance angiography were performed to understand the infarct patterns and to exclude intracranial artery stenosis. The modified American Heart Association (AHA) plaque classification was used in our study. Results: Our study demonstrated that 45 patients had CA stroke, and 55 patients had lacunar and asymptomatic lesions. The majority of patients had AHA classification type IV–V and VI which presented as vulnerable plaques. Of 63 patients with mild to moderate stenosis (≤70%), 44 (69.8%) had type IV–V vulnerable plaques, which was significantly higher than those of patients with severe stenosis (>70%; p < 0.001). In CA stroke, the number of patients with a thin or ruptured fibrous cap was twice that of those with a thick and intact fibrous cap. Conclusions: CEMRI may have important applications in clinical risk evaluations in CA atherosclerosis. Physicians ought to recognize that different types of stroke should be identified by brain MRI detection before invasive therapies.

Keywords:
Atherosclerosis, Carotid arteries, Stroke, Magnetic resonance imaging
1.
Thorvaldsen P, Kuulasmaa K, Rajakangas AM, et al: Stroke trends in the WHO MONICA project. Stroke 1997;28:500–506.
2.
Hennerici M, Hulsbomer HB, Hefter H, et al: Natural history of asymptomatic extracranial arterial disease: results of a long-term prospective study. Brain 1987;110:777–791.
3.
Wasserman BA, Wityk RJ, Trout HH 3rd, et al: Low-grade carotid stenosis: looking beyond the lumen with MRI. Stroke 2005;36:2504–2513.
4.
Carr S, Farb A, Pearce WH, et al: Atherosclerotic plaque rupture in symptomatic carotid artery stenosis. J Vasc Surg 1996;23:755–765.
5.
Yuan C, Kerwin WS, Ferguson MS, et al: Contrast-enhanced high resolution MRI for atherosclerotic carotid artery tissue characterization. J Magn Reson Imaging 2002;15:62–67.
6.
Saam T, Hatsukami TS, Takaya N, et al: The vulnerable, or high-risk, atherosclerotic plaque: noninvasive MR imaging for characterization and assessment. Radiology 2007;244:64–77.
7.
Inzitari D, Lamassa M: Small-vessel disease with lacunes. Adv Neurol 2003;92:141–146.
8.
Inzitari D, Eliasziw M, Gates P, et al: The causes and risk of stroke in patients with asymptomatic internal-carotid-artery stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 2000;342:1693–1700.
9.
Yuan C, Mitsumori LM, Beach KW, et al: Carotid atherosclerotic plaque: noninvasive MR characterization and identification of vulnerable lesions. Radiology 2001;221:285–299.
10.
Phan BA, Chu B, Kerwin WS, et al: Effect of contrast enhancement on the measurement of carotid arterial lumen and wall volume using MRI. J Magn Reson Imaging 2006;23:481–485.
11.
Fayad ZA, Fuster V: Characterization of atherosclerotic plaques by magnetic resonance imaging. Ann NY Acad Sci 2000;902:173–186.
12.
Hatsukami TS, Ross R, Polissar NL, et al: Visualization of fibrous cap thickness and rupture in human atherosclerotic carotid plaque in vivo with high-resolution magnetic resonance imaging. Circulation 2000;102:959–964.
13.
Chu B, Kampschulte A, Ferguson MS, et al: Hemorrhage in the atherosclerotic carotid plaque: a high-resolution MRI study. Stroke 2004;35:1079–1084.
14.
Cai JM, Hatsukami TS, Ferguson MS, et al: Classification of human carotid atherosclerotic lesions with in vivo multicontrast magnetic resonance imaging. Circulation 2002;106:1368–1373.
15.
Naghavi M, Libby P, Falk E, et al: From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies. Part I. Circulation 2003;108:1664–1672.
16.
North American Symptomatic Carotid Endarterectomy Trial Collaborators: Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1999;325:445–453.
17.
Moreno PR, Falk E, Palacios IF, et al: Macrophage infiltration in acute coronary syndromes: implications for plaque rupture. Circulation 1994;90:775–778.
18.
Yuan C, Kerwin WS, Yarnykh VL, et al: MRI of atherosclerosis in clinical trials. NMR Biomed 2006;19:636–654.
19.
Virmani R, Burke AP, Kolodgie FD, et al: Vulnerable plaque: the pathology of unstable coronary lesions. J Interv Cardiol 2002;15:439–446.
20.
Yuan C, Zhang SX, Polissar NL, et al: Identification of fibrous cap rupture with magnetic resonance imaging is highly associated with recent transient ischemic attack or stroke. Circulation 2002;105:181–185.
21.
Tsiskaridze A, Devuyst G, de Freitas GR, et al: Stroke with internal carotid artery stenosis. Arch Neurol 2001;58:605–609.
22.
Szabo K, Kern R, Gass A, et al: Acute stroke patterns in patients with internal carotid artery disease: a diffusion-weighted magnetic resonance imaging study. Stroke 2001;32:1323–1329.
23.
Inzitari D, Eliasziw M, Sharpe BL, et al: Risk factors and outcome of patients with carotid artery stenosis presenting with lacunar stroke. Neurology 2000;54:660–666.
24.
Virmani R, Ladich ER, Burke AP, et al: Histopathology of carotid atherosclerotic disease. Neurosurgery 2006;59(suppl 3):S219–227.
25.
Redgrave JN, Lovett JK, Gallagher PJ, et al: Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms: the Oxford Plaque Study. Circulation 2006;113:2320–2328.
26.
Spagnoli LG, Mauriello A, Sangiorgi G, et al: Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke. JAMA 2004;292:1845–1852.
27.
Bassiouny HS, Davis H, Massawa N, et al: Critical carotid stenoses: morphologic and chemical similarity between symptomatic and asymptomatic plaques. J Vasc Surg 1989;9:202–212.
28.
Burke AP, Kolodgie FD, Farb A, et al: Healed plaque ruptures and sudden coronary death: evidence that subclinical rupture has a role in plaque progression. Circulation 2001;103:934–940.
29.
Gillard JH: Advances in atheroma imaging in the carotid. Cerebrovasc Dis 2007;24 (suppl 1):40–48.
© 2009 S. Karger AG, Basel
2009
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.